I have recently reentered the stock. I was curious as to the discussion of the changing CMO officers so i asked someone who is very involved in the pharma industry. The answer is CMO are bought in based on their expertise at particular points of a drug development, short stints are very common and many have multiple gigs at once. Yhey were very certain this is very common in phragma and nothing to be worried about
Its interesting what you can find out with some research
They are across this company and their drugs and big believers (as an aside )
Ann: Imugene Appoints Dr Weitzman Interim Chief Medical Officer, page-99
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.6¢ |
Change
-0.002(4.17%) |
Mkt cap ! $342.1M | |||
| Open | High | Low | Value | Volume |
| 4.8¢ | 4.8¢ | 4.6¢ | $400.2K | 8.603M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 17 | 1876197 | 4.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.7¢ | 613421 | 6 |
View Market Depth
| Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |